Desferrioxamine ๐
Always check the BNF link here ๐ for up-to-date prescribing advice.
- Desferrioxamine is a chelating agent used to treat iron and aluminium overload ๐งฒ.
โ๏ธ Mode of Action
- Binds free iron (ferric Feยณโบ) and aluminium to form stable, water-soluble complexes (ferrioxamine, aluminoxamine).
- These complexes are excreted in urine and bile, reducing toxic metal accumulation.
๐ Indications & Dose
| Indication | Dose / Frequency | Route |
| Iron & aluminium toxicity |
15 mg/kg/h (max 80 mg/kg/24 h) |
IV infusion |
| Chronic iron overload (e.g. transfusion-dependent thalassaemia) |
20โ40 mg/kg/day, up to 5โ7 days per week |
SC infusion (over 8โ12 h) |
๐ก Chelated iron produces reddish urine (โvin rosรฉโ colour) - useful clinical clue.
โ ๏ธ Interactions
- See BNF. Use with caution with vitamin C (high doses may โ risk of cardiac dysfunction when combined).
๐ Cautions
- Rapid infusion may cause hypotension and collapse.
- Monitor for visual and auditory disturbances with prolonged use ๐๐.
- Infection risk: desferrioxamine predisposes to Yersinia and Mucormycosis ๐ฆ .
๐ซ Contraindications
- Severe renal impairment (drug excreted renally).
- Hypersensitivity to desferrioxamine.
โ Side Effects
- Local pain at IM/SC injection site ๐.
- Hypotension if infused too rapidly.
- Acute lung injury / ARDS (rare) ๐ซ.
- GI upset: abdominal pain, nausea ๐คข.
- Red urine due to ferrioxamine complex.
- Risk of opportunistic infections (Yersinia, mucormycosis).
๐ References
๐ Revisions
- Latest update: expanded indications (acute vs chronic), added infection risk and monitoring requirements.